Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 12 studies | 32% ± 13% | |
| endothelial cell of lymphatic vessel | 10 studies | 23% ± 6% | |
| platelet | 8 studies | 29% ± 9% | |
| endothelial cell | 5 studies | 22% ± 5% | |
| GABAergic neuron | 4 studies | 27% ± 9% | |
| astrocyte | 4 studies | 23% ± 6% | |
| epithelial cell | 4 studies | 25% ± 4% | |
| glial cell | 3 studies | 18% ± 1% | |
| megakaryocyte | 3 studies | 31% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 29% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4595.95 | 244 / 245 | 100% | 184.46 | 502 / 502 |
| brain | 100% | 5038.84 | 2633 / 2642 | 100% | 81.02 | 704 / 705 |
| kidney | 100% | 3645.96 | 89 / 89 | 98% | 67.46 | 880 / 901 |
| esophagus | 100% | 4296.20 | 1445 / 1445 | 97% | 49.22 | 177 / 183 |
| breast | 100% | 3868.86 | 459 / 459 | 96% | 51.17 | 1076 / 1118 |
| skin | 100% | 5914.32 | 1808 / 1809 | 96% | 82.32 | 454 / 472 |
| intestine | 100% | 4125.43 | 966 / 966 | 96% | 36.06 | 505 / 527 |
| lung | 98% | 3171.37 | 567 / 578 | 95% | 55.41 | 1097 / 1155 |
| thymus | 100% | 3169.29 | 650 / 653 | 93% | 80.16 | 561 / 605 |
| bladder | 100% | 3164.24 | 21 / 21 | 91% | 37.16 | 458 / 504 |
| uterus | 99% | 4396.18 | 169 / 170 | 89% | 38.40 | 410 / 459 |
| ovary | 98% | 2826.31 | 176 / 180 | 90% | 32.19 | 386 / 430 |
| adrenal gland | 95% | 2308.42 | 244 / 258 | 90% | 54.75 | 207 / 230 |
| stomach | 75% | 1855.94 | 268 / 359 | 91% | 31.33 | 261 / 286 |
| pancreas | 19% | 235.10 | 61 / 328 | 96% | 48.99 | 171 / 178 |
| blood vessel | 100% | 11054.51 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4952.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.83 | 1 / 1 |
| adipose | 100% | 4490.49 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 4199.59 | 795 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 58.74 | 76 / 80 |
| heart | 89% | 1783.67 | 764 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 31.60 | 38 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 18.25 | 22 / 29 |
| liver | 9% | 117.92 | 20 / 226 | 24% | 10.14 | 96 / 406 |
| peripheral blood | 29% | 916.48 | 267 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045087 | Biological process | innate immune response |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0003676 | Molecular function | nucleic acid binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0004519 | Molecular function | endonuclease activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ENDOD1 |
| Protein name | Endonuclease domain-containing 1 protein (EC 3.1.30.-) |
| Synonyms | KIAA0830 |
| Description | FUNCTION: May act as a DNase and a RNase. Plays a role in the modulation of innate immune signaling through the cGAS-STING pathway by interacting with RNF26. . |
| Accessions | ENST00000278505.5 O94919 |